🇺🇸 FDA
Patent

US 10576145

CD200 inhibitors and methods of use thereof

granted A61KA61K2039/55516A61K2039/55561

Quick answer

US patent 10576145 (CD200 inhibitors and methods of use thereof) held by Regents of the University of Minnesota expires Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Mar 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/55516, A61K2039/55561, A61K39/0011, A61K39/39